PACTG 1025: PERINATAL CORE PROTOCOL (AIDS)

PACTG 1025：围产期核心方案（艾滋病）

• 批准号: 7605703
• 负责人: William Borkowsky
• 金额: $ 24.58万
• 依托单位: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7605703
• 关键词: Acquired Immunodeficiency Syndrome; Adherence; Child; Complex; Computer Retrieval of Information on Scientific Projects Database; Controlled Study; Data Collection; Enrollment; Funding; Future; Grant; HIV; Infant; Institution; Intervention; Mothers; Multicenter Trials; Outcome; Perinatal; Pharmaceutical Preparations; Population; Pregnancy; Pregnant Women; Protocols documentation; Research; Research Personnel; Resources; Risk Factors; Safety; Site; Source; Specimen; Toxic effect; Treatment Efficacy; Treatment Protocols; United States National Institutes of Health; Vertical Disease Transmission; antiretroviral therapy; fetal; prevent; repository

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The efficacy of antiretroviral therapy in preventing vertical transmission of HIV is undisputed. The investigators note, however, that a small percentage of children born to HIV-infected mothers are infected. Doing a controlled study in this population is unethical. Thus the PACTG will follow approximately 2400 mother/infant pairs who will be treated at PACTG sites and determine which children become infected, to which drug regimens their mothers were prescribed, how difficult it was to follow the regimen and how closely they adhered to it. They will compare efficacy of interventions prescribed, safety of interventions prescribed and adherence to antiretroviral therapy by HIV-infected pregnant women and its impact on vertical transmission. They will also establish a repository for specimens for future studies to evaluate risk factors and outcomes. They hypothesize that adherence will be better during pregnancy than post-partum; more complex regimens will have poorer adherence; toxicity will give poorer adherence. This study will help evaluate issues in treating pregnant women with HIV. Many are already enrolled in treatment studies. Uniformity of data collection and determination of fetal outcomes will provide much needed information regarding best treatment during pregnancy. Enrollment has begun and is continuing on this multicenter trial.

这个子项目是众多研究子项目之一